Pediatrix Medical Group, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $320.4M | $324.9M | $336.3M | $317.3M | $280.5M | $240.9M | $218.0M | $202.7M |
| Depreciation & Amortization | $78.9M | $89.3M | $64.2M | $46.0M | $40.0M | $30.8M | $25.3M | $22.0M |
| Depreciation | $26.4M | $29.0M | $22.2M | $15.9M | $15.5M | $15.8M | $15.0M | $13.5M |
| Amortization | $52.5M | $60.3M | $42.0M | $30.1M | $24.5M | $15.0M | $10.3M | $8.5M |
| Stock-Based Compensation | $28.8M | $34.0M | $32.1M | $31.7M | $31.3M | $28.4M | $27.1M | $25.7M |
| Net Cash from Operating Activities | $511.4M | $443.8M | $368.7M | $422.6M | $405.4M | $324.9M | $270.7M | $240.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $26.2M | $39.3M | $27.1M | $18.1M | $15.7M | $14.5M | $31.3M | $12.1M |
| Business Acquisitions | $531.2M | $762.3M | $818.9M | $479.4M | $238.0M | $441.0M | $154.9M | $338.6M |
| Net Cash from Investing Activities | $-576.6M | $-821.2M | — | — | $-263.5M | $-460.5M | $-190.6M | $-361.6M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $70.2M | $61.8M | $235.1M | $488.4M | $51.9M | — | — | — |
| Net Cash from Financing Activities | $89.7M | $381.6M | — | — | $-132.1M | $138.3M | $-87.8M | $120.8M |
| Net Change in Cash | $24.5M | $4.1M | $3.6M | $16.8M | $9.9M | $2.7M | $-7.7M | $-252.0K |
| Free Cash Flow | $485.2M | $404.5M | $341.6M | $404.6M | $389.7M | $310.4M | $239.3M | $228.4M |